Drug Shortage Report for TEVA-DILTIAZEM XC
Report ID | 221546 |
Drug Identification Number | 02429357 |
Brand name | TEVA-DILTIAZEM XC |
Common or Proper name | DILTIAZEM XC 360MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 360MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-03-06 |
Estimated end date | 2024-05-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-25 | French | Compare |
v5 | 2024-04-25 | English | Compare |
v4 | 2024-03-14 | French | Compare |
v3 | 2024-03-14 | English | Compare |
v2 | 2024-03-07 | French | Compare |
v1 | 2024-03-07 | English | Compare |
Showing 1 to 6 of 6